[What is the place of bioresorbable vascular scaffolds in setting of ST-segment elevation myocardial infarction?].. Quelle place pour les stents biorésorbables dans la prise en charge du syndrome coronarien aigu avec sus-décalage du segment ST ?

Archive ouverte

Lattuca, B. | Schmutz, L. | Ledermann, B. | Cornillet, L. | Messner-Pellenc, P. | Leclercq, F. | Cayla, G.

Edité par CCSD ; Elsevier Masson -

International audience. A 50-year-old woman was admitted for an inferior ST-segment elevation myocardial infarction; immediate coronary angiogram revealed a subocclusive stenosis of the right coronary artery. After optimal antithrombotic treatment, the type of stent could be discussed. The latest generation of drug-eluting stents showed excellent efficacy and safety in the long-term but has limitations such as potential chronic inflammation of the arterial wall and no recovery of vasoactive function. Bioresorbable vascular scaffolds, with complete resorption within several months, may reduce these limitations. Implantation of bioresorbable scaffold in the context of myocardial infarction may be interesting. However, very few studies are currently available in this setting. Preliminary results and perspectives are presented in this review.

Consulter en ligne

Suggestions

Du même auteur

Assessment of peak skin dose in interventional cardiology: A comparison between Gafchromic film and dosimetric software em.dose

Archive ouverte | Greffier, J. | CCSD

International audience. OBJECTIVE:To compare the use of a dose mapping software to Gafchromic film measurement for a simplified peak skin dose (PSD) estimation in interventional cardiology procedure.METHODS:The stud...

Assessment of Patient's Peak Skin Dose Using Gafchromic Films During Interventional Cardiology Procedures: Routine Experience Feedback

Archive ouverte | Greffier, J. | CCSD

International audience. To assess the interest of Gafchromic films in detection of patient's peak skin dose (PSD) in interventional cardiology. A prospective study of 112 patients was conducted (July-December 2015)....

[Which patient for TAVI in 2019?]. À quel patient proposer un TAVI en 2019 ?

Archive ouverte | Cayla, G. | CCSD

International audience. The therapeutic management of aortic stenosis has been drastically changed by the advent of percutaneous valve replacement (TAVI). Since the first implantation, the indications have progressi...

Chargement des enrichissements...